Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
02/2015
02/19/2015WO2015022332A1 Pyridinones
02/19/2015WO2015022038A1 3-substituted cyclopentylamine derivatives
02/19/2015WO2015021833A1 Conjugated diene derivatives, preparation method therefor, and uses thereof as anticancer drug
02/19/2015US20150051405 New 1,2,4-oxadiazol derivatives, process for their preparation and use thereof as intermediates in the preparation of indolic alkaloids
02/19/2015US20150051257 Sulphonamide derivatives of benzylamine for the treatment of cns diseases
02/19/2015US20150051248 Imidazolyl methyl piperidine t-type calcium channel antagonists
02/19/2015US20150051238 Pyrazole aminopyrimidine derivatives as lrrk2 modulators
02/19/2015US20150051233 Methods and compositions for treatment of fibrosis
02/19/2015US20150051208 Pyridinones
02/19/2015US20150051195 Novel viral replication inhibitors
02/19/2015US20150051187 Compounds useful as inhibitors of atr kinase
02/19/2015US20150050239 Substituted pyrazolone compounds and methods of use
02/18/2015EP2837628A1 Method for preparing rivaroxaban intermediate
02/18/2015EP2837624A1 4-substituent-2-hydroxylmorpholine-3-one and preparation method thereof
02/18/2015EP2837620A1 Aryloxyurea compound and pest control agent
02/18/2015EP2836490A2 Indole and indazole compounds that activate ampk
02/18/2015EP2836487A1 Heterocyclic compounds and uses thereof
02/18/2015EP2836486A1 Diaminopyrimidines useful as inhibitors of the human respiratory syncytial virus (rsv)
02/17/2015US8958165 Cyanine compound and optical filter and optical recording material containing same
02/17/2015US8957216 Heterocyclic compounds useful for kinase inhibition
02/17/2015US8957206 Methods of producing molindone and its salts
02/17/2015US8957205 Cycloalkane carboxamide derivatives and production process of same
02/17/2015US8957105 Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
02/17/2015US8957094 Therapeutic agent or prophylactic agent for fibromyalgia
02/17/2015US8957093 N-biphenylmethylindole modulators of PPARG
02/17/2015US8957089 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
02/17/2015US8957081 Compounds and compositions as protein kinase inhibitors
02/17/2015US8957073 Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitors
02/17/2015US8957070 Glucokinase activator compounds, methods of activating glucokinase and methods of treating diabetes and obesity
02/17/2015US8957069 Benzofuran derivatives
02/17/2015US8957068 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
02/17/2015US8957063 Amine and ether compounds which modulate the CB2 receptor
02/17/2015US8957062 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment
02/17/2015CA2647423C Triazolone derivative
02/17/2015CA2592509C Benzazole analogues and uses thereof
02/12/2015WO2015020933A1 Thiazole orexin receptor antagonists
02/12/2015WO2015020930A1 Oxazole orexin receptor antagonists
02/12/2015WO2015020184A1 Aromatic compound
02/12/2015WO2015019725A1 Organic metal complex, luminescent material, delayed phosphor and organic light emitting element
02/12/2015WO2015019365A1 N-cyanomethylamides as inhibitors of janus kinase
02/12/2015WO2015019325A1 Benzimidazolyl-methyl urea derivatives as alx receptor agonists
02/12/2015WO2015019121A1 Styryl quinazoline derivatives as pharmaceutically active agents
02/12/2015WO2015018754A1 Novel pyrazine amide compounds
02/12/2015WO2015018029A1 Oxazole orexin receptor antagonists
02/12/2015US20150045554 Synthesis of raltegravir
02/12/2015US20150045402 Heterocyclic acetamide compound
02/12/2015US20150045399 Liver X Receptor (LXR) Modulators For The Treatment Of Dermal Diseases, Disorders And Conditions
02/12/2015US20150045394 Carboxamide compounds and their use as calpain inhibitors
02/12/2015US20150045368 Oxazolidinone compounds and derivatives thereof
02/12/2015US20150045359 Morpholine compounds and uses thereof
02/12/2015US20150045344 4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof
02/12/2015US20150045339 Nitrogen-containing heterocyclic compound or salt thereof
02/12/2015US20150045326 Novel pyrazine amide compounds
02/11/2015EP2835371A1 Industrial method for manufacturing high-purity methiozoline
02/11/2015EP2834235A1 Processes for preparing rivaroxaban
02/11/2015EP2834234A1 Fused cyclopentyl antagonists of ccr2
02/11/2015CN104350053A 杂芳族甲基环胺衍生物 Heteroaromatic methyl cyclic amine derivative
02/11/2015CN104350052A 一氧化氮供体脑啡肽酶抑制剂 Nitric oxide donor neprilysin inhibitor
02/11/2015CN104350051A 用于糖尿病的异*唑治疗剂 * Azole different therapeutic agent for diabetes
02/11/2015CN104350040A 芳环化合物 Aromatic compounds
02/11/2015CN104342126A 有机电致发光材料和有机电致发光器件 Organic electroluminescent materials and organic electroluminescent devices
02/11/2015CN104341408A 一种阿奇沙坦的新晶型及其制备方法 Archie Chastain one kind of new crystal form and its preparation method
02/11/2015CN104341407A 喹唑啉类化合物及其制备方法和用途 Quinazoline compounds and their preparation and use
02/11/2015CN104341388A 芳香族酰胺类衍生物、其制备方法及其在医药上的应用 Aromatic amide derivatives, their preparation and their use in medicine
02/11/2015CN104341386A 一类芳基杂环小分子化合物、其衍生物及其制备方法和用途 A class of small molecule aromatic heterocyclic compounds, their derivatives and its preparation method and use
02/11/2015CN103025724B 哌啶衍生物 Piperidine derivatives
02/11/2015CN102791687B C型肝炎病毒复制的新型抑制剂 Novel inhibitors of hepatitis C virus replication
02/11/2015CN102659772B 一种与Aβ斑块有亲和力的2-芳基苯并杂环化合物及其制备方法和应用 One kind of affinity with Aβ plaques 2 arylbenzo heterocyclic compounds and its preparation method and application
02/11/2015CN102656165B 糖苷衍生物及其用途 Glycoside derivatives and their use
02/11/2015CN102639500B 三环化合物、其制备方法及其在医药上的应用 Tricyclic compounds, their preparation and their use in medicine
02/11/2015CN102174024B 2,4-嘧啶二胺化合物及其用途 2,4-pyrimidinediamine compounds and use thereof
02/11/2015CN101851235B 杂环化合物、使用杂环化合物的发光元件、发光装置、照明装置及电子设备 Heterocyclic compounds, heterocyclic compounds using the light-emitting element, a light emitting device, a lighting device and electronic equipment
02/10/2015US8952207 Copper-catalyzed C—H bond arylation
02/10/2015US8952176 Heterocyclic compound having type I 11 β hydroxysteroid dehydrogenase inhibitory activity
02/10/2015US8952169 N-substituted benzamides and methods of use thereof
02/10/2015US8952161 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
02/10/2015US8952157 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
02/10/2015US8952058 Heterocyclic compounds and methods of use thereof
02/10/2015US8952042 FXR (NR1H4) binding and activity modulating compounds
02/10/2015US8952041 Modulators of sperm hypermobility and uses thereof
02/10/2015US8952037 Heteroaryloxycarbocyclyl compounds as PDE10 inhibitors
02/10/2015US8952027 Inhibitors of syk and JAK protein kinases
02/10/2015US8952024 Herbicidal pyrimidone derivatives
02/10/2015US8952010 Amino group-containing pyrrolidinone derivative
02/10/2015US8952007 Fused heterocyclic compounds as ion channel modulators
02/10/2015US8952006 Morpholinoalkyl fumarate compounds, pharmaceutical compositions, and methods of use
02/10/2015US8952004 CXCR3 receptor antagonists
02/10/2015US8951536 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
02/10/2015CA2668280C 5-hydroxymethyl-oxazolidin-2-one derivatives
02/05/2015WO2015017589A1 1,4-disubstituted pyridazine derivatives and their use for treating smn-deficiency-related conditions
02/05/2015WO2015016335A1 Tetrazolinone compound and use thereof
02/05/2015WO2015016206A1 Heterocyclic compound
02/05/2015WO2015016200A1 Compound, light-emitting material, and organic light-emitting element
02/05/2015WO2015016195A1 Wnt SIGNALING INHIBITOR
02/05/2015WO2015014816A1 1,2-disubstituted cyclobutyl compounds
02/05/2015WO2015014446A1 1,3-disubstituted cyclopentane derivatives
02/05/2015WO2015014442A1 Oxoquinazolinyl-butanamide derivatives
02/05/2015US20150038704 Method for preparing rivaroxaban intermediate
02/05/2015US20150038534 Compounds and methods
02/05/2015US20150038501 Inhibitors of hcv ns5a
1 2 3 4 5 6 7 8 9 10 11 12 ... 647